Clinical and laboratory aspects of the Aspirin-like defect as hereditary thrombocytopathy;Klinische und Labordiagnostische Aspekte des Aspirin-like Defekts als Hereditare Thrombozytopathie

Hamostaseologie

Volumn 29, Issue 2, 2009, Pages 177-183

  Rolf, N ^a,c   Bugert, P ^b   Gehrisch, S ^a   Siegert, G ^a   Suttorp, M ^a   Knofler R ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Institute of Transfusion Medicine   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aspirin like defect; Children; Inherited platelet function disorder

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; ASPIRIN LIKE DEFECT; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; EPISTAXIS; HEMOSTASIS; HUMAN; LABORATORY TEST; MENORRHAGIA; PERIOPERATIVE PERIOD; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPATHY;

EID: 66749147422     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617020     Document Type: Article

References (24)

1. Bolton-Maggs PHB, Chalmers EA, Collins PW et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135: 603-633.
2. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002; 141: 683-688.
3. Dube JN, Drouin J, Aminian M et al. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. Br J Haematol 2001; 113: 878-885.
4. 2: Biosynthesis and effects on platelets. Adv Prostaglandin Thromboxane Leu- kot Res 1982; 10: 15-58.
5. Harrison P, Robinson MS, Mackie IJ et al. Performance of the platelet function analyzer PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis 1999; 10: 25-31.
6. Harrison P, Robinson M, Liesner R et al. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol 2002; 24: 225-232.
7. Hayward CP, Harrison P, Cattaneo M et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312-319.
8. Hayward CPM, Rao AK, Cattaneo M. Congenital platelet disorders: overview of their mechanism, diagnostic evaluation and treatment. Haemophilia 2006; 12: 128-136.
9. 2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 1994; 94: 1662-1667.
10. Jayasinghe Y, Moore P, Donath S et al. Bleeding disorders in teenagers presenting with men-orrhagia. Aust N Z J Obstet Gynaecol 2005; 45: 439-443.
11. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-163.
12. Khair K, Liesner R. Bruising and bleeding in infants and children - a practical approach. Br J Haematol 2006; 133: 221-231.
13. Kouides PA. Evaluation of abnormal bleeding in woman. Curr Hematol Rep 2002; 1: 11-18.
14. Maguire S, Mann MK, Sibert J et al. Are there patterns of bruising in childhood which are diagnostic or suggestive of abuse? A systematic review. Arch Dis Child 2005; 90: 182-186.
15. Matijevic-Aleksic N, McPhedran P, Wu KK. Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency. Br J Haema- tol 1996; 92: 212-217.
16. Nyman D, Eriksson AW, Lehmann W et al. Inherited defective platelet aggregation with arac- hidonate as the main expression of a defective metabolism of arachidonic acid. Thromb Res 1979; 14: 739-746.
17. Philipp CS, Dilley A, Miller CH et al. Thromb Haemost 2003; 1: 477-484.
18. Ramasamy I. Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematol 2004; 49: 1-35.
19. Rao AK. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 1998; 316: 69-76.
20. Rao AK, Jalagadugula G, Sun L. Inherited defects in platelet signalling mechanisms. Semin Thromb Haemost 2004; 30: 525-535.
21. Rolf N, Knoefler R, Bugert P et al. Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families. Br J Haematol 2009; 144: 416-424.
22. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-2093.
23. Vane JR, Bakhle YS, Botting RM. Cyclooxygenase 1 and 2. Ann Rev Pharmacol Toxicol 1998; 38: 97-120.
24. Weiss HJ, Rogers J. Thrombocytopathia due to abnormalities in platelet release reaction - studies on six unrelated patients. Blood 1972; 39: 187-196.